In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 41014-43-1, name is 2-(Chloromethyl)benzo[d]oxazole, introducing its new discovery. 41014-43-1
New 1,2,4-triazine derivatives and biological applications thereof
The invention relates to new 1,2,4-triazine derivatives of formula (I): wherein A, B, R2 and Y are defined in the application, their preparation and intermediates, their use as drugs and pharmaceutical compositions and associations containing them.The compounds of formula (I) are capable of inhibiting bacterial heptose synthesis.The invention relates to new 1,2,4-triazine derivatives of formula (I): wherein A, B, R2 and Y are defined in the application, their preparation and intermediates, their use as drugs and pharmaceutical compositions and associations containing them. The compounds of formula (I) are capable of inhibiting bacterial heptose synthesis.
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.41014-43-1, you can also check out more blogs about41014-43-1
Reference£º
Benzoxazole – Wikipedia,
Benzoxazole | C7H5NO – PubChem